Issuu on Google+

The definitiv definitive e guide to Hospitals and Healthcar Healthcare e in the

MIDDLE EAST HOSPIT HOSPITAL SPITTA AL

Middle East

WEILL CORNELL MEDICAL COLLEGE IN QATAR – h and Innov alt at He

ward nA io

MEH 2 01 0

Spearheading Educational Excellence in the region

outstanding contribution to healthcare in the Middle East

MIDDLE EAST HOSPITAL Health & Innovations Awards nominations, Saudi Medicare 2011

Arab Health 2011, World Health Care Congress Middle East Review Dr Abdulrahman Al Mishari Hospital – Saudi Healthcare excellence Healthcare in the UAE at the Crossroads by Nusrate Ibrahim h and Innov alt at He

ward nA io

MEH 2 01 0

MEDICA 2010 Special Feature outstanding contribution to healthcare in the Middle East

MIDDLE EAST HOSPITAL Health & Innovations Awards 2010 Nominations

SAUDI MEDICARE 2011 Al Mishariwith Hospital – Interview Saudi Healthcare Snoring DisordersExcellence Centre founder

Dr Michael Oko ABU DHABI WORLD HEALTH CONGRESS

Mirage Health Group

HEALTHCARE MANAGEMENT FORUM 2011 – Malem Medical – HEALTHCARE INSURANCE FORUM 2011 World leader in Enuresis Alarms

Adam,Rouilly Medibord

www.middleeasthospital.com www .middleeasthosp pital.com


Be where the world is going & growing

The 14th International Healthcare, Hospital Supplies and Medical Equipment Show

10 - 13 APRIL 2011 Riyadh International Convention & Exhibition Center


Middle East Hospital

January 2011 contents

Editor’s intro 4.

January is an important month for the healthcare industry in the Middle East, with Arab Health in Dubai a key date in the calendar. MEH will be at the event with a stand in Dubai Room A. This follows hot on the heels of Medica, and the inaugural World Health Care Congress Middle East, a new and prestigious health care event convening global thought leaders and key decision makers from all sectors of healthcare to share global best practices on health care innovation and improvement. This took place in Abu Dhabi in December, with MEH official media partners. Looking at the year ahead, the next key industry gathering in the region will be at Saudi Medicare 2011, from 10-13 April. The Saudi market is the largest and therefore most important in the Gulf, and the growth of this show, now in its 14th year, reflects the opportunities for exporters of medical equipment to the Kingdom. MEH is the lead media partner, and we preview the event in this issue. For those interested in finding out more about the Saudi market, and making local contacts, there will be a reception during Arab Health at the Fairmont in Dubai on 26 January from 6.308.30pm. The MEH 2010 Health and Innovation awards nominations are Editor: Guy Rowland Publisher: Mike Tanousis Associate Publisher: Chris Silk MEH Publishing Limited Company Number 7059215 151 Church Rd Shoeburyness Essex SS3 9EZ United Kingdom Tel: 0044 1702 296776

COVER FEATURE Weill Cornell Medical College in Qatar:

28.

MEH Health 2010 and Innovation awards nominees: rewarding compa nies and providers making oustanding contri butions to healthcare in the Middle East

34.

Mirage Health Group: New ear care productsProScoop and ProTect launched at Arab Health

36.

Philips Healthcare: Obstructive Sleep Apnea in the Middle East and the benefits of CPAP treatment

42.

Interview with Dr Michael Oko: consultant ENT surgeon and founder of the Snoring Disorders Centre

44.

World Health Care Congress Middle East: Post-congress report

48.

Special report: Diabetes in the Gulf and MENA region

working on multiple fronts to improve healthcare in Qatar 12.

Arab Health 2011 Preview

14.

Adam,Rouilly: over 90 years of medical training expertise

16.

Healthcare in the UAE at the crossroads: expert article by Nusrate Ibrahim of Deloitte

22.

Malem Medical: world leaders in enuresis alarms

24.

Saudi Medicare 2011: conference preview- 10-13 April 2011 in Riyadh

26.

Dr Abdulrahman Al Mishari Hospital: special feature on the leading Saudi hospital

33.

UK Pavilion at Arab Health

well underway, with some of the nominees featured in this issue. Lord Darzi, UK business ambassador, will present some of the UK nominees with their certificates at Arab Health in the Novotel at 5pm on 24 January. Our cover feature this month is a profile of the internationally renowned Weill Cornell Medical

Mobile: 0044 0776 1202468 Skype -mike.tanousis1 MEH French office Guy Rowland Tel : 0033 952160441 guyrowland@middleeasthospital.com MEH agent for Egypt Dr.Amr Salah Millennium International Group (Managing Director)

College in Qatar, in which we look at the contribution the college is making to heathcare in the region. Also featured is an interview with Dr Michael Oko, founder of the UK based Snore Centre, who will be at Arab Health to raise awareness of the problems caued by sleep apnea in the Middle East.

amr.salah@migaegypt.com Tel: +2 0222736354 Fax: +2 022747691 Mobile: +2 0122227209 UAE distributor Dr Prem Jagyasi MD & CEO ExHealth 501 Ibn Sina Building P. O. Box. 505131 Dubai HealthCare City, UAE

Tel:+971 4 437 0170 Prem@Jagyasi.comm www.ExHealth.com To discuss the submission of an article for Middle East Hospital magazine please email editorial@middleeasthospital.com

January 2011 | 3


Middle East Hospital

Weill Cornell Medical College in Qatar Working on Multiple Fronts to Improve Health Care in Qatar

As it completes its first decade, Weill Cornell Medical College in Qatar has graduated 49 new physicians, established a research program focused on the genetic and molecular basis of diseases challenging the Gulf Region and the world, and expanded access to superior clinical care for the country’s fast-growing population. “As we advance our triple mission of excellence in education, research and clinical care, we are implementing the vision of Her Highness Sheika Mozah Bint Nasser Al Missned for a knowledge-based society and a sustainable economy in Qatar,” says Javaid sheikh, M.D., dean of WCMC-Q. From its start, with 25 students in the premedical program, the medical college has grown rapidly to more than 262 students from 35 countries. Following the curriculum

of Weill Cornell Medial College in the United States, the medical college introduced to Qatar coeducation at the university level and the problem-based learning method with its emphasis on independent, self-directed study to increase knowledge and understanding and facilitate communication skills and teamwork. The graduation of its fourth class in May brings to more than 75 the number of physicians who have received the M.D. degree from Cornell University. These new doctors are now enrolled in residency or fellowship training programs with renowned hospitals in the United States and at Hamad Medical Corporation in Qatar, the country’s leading non-profit health care provider. As they continue their training, many of these young doctors are making their mark on the institutions they join. Subhi Al Aref, M.D., a graduate of WCMC-Q’s inaugural class of 2008, was recently appointed to a four-year

term on the board of directors of the WCMC Alumni Association, the first appointment from the Qatar campus. A senior resident in internal medicine at NewYorkPresbyterian Hospital, Dr. Al Aref recently received an interventional cardiology fellowship as well. Imran Farooq, M.D., a 2009 graduate, was recently named chief resident of internal medicine at the Medical College of Virginia at Virginia Commonwealth University. Additionally, his gastroenterology research will be presented in May at a large gastroenterology conference in the U.S. As the graduates increase in number, they advance the reputation of WCMC-Q in the wide range of organizations they join. An Oasis for Research and New Knowledge Through its biomedical research program, WCMC-Q scientists and researchers are investigating the genetic and molecular causes of diseases challenging the Gulf Region and the world.

January 2011 | 4


Middle East Hospital

With strong financial support from Qatar Foundation, WCMC-Q has established a strong research infrastructure with core laboratories shared by the entire research department, supporting multiple experiments and studies for basic and clinical research. Core facilities established to date include: • a genomics core that provides DNA and RNA analysis services • an imaging core to improve understanding of cellular physiology; and • a biostatics core, with expertise in study design and data analysis related to clinical studies. While establishing the genomics core laboratory two years ago, WCMC-Q researchers tackled sequencing the date palm genome as a proof of concept project to validate the capabilities of the lab. Within two months, the team was able to generate a draft DNA sequence of the genome. “We increased a thousand fold the publicly available knowledge of the

date palm gene space,” says Joel Malek, director of the genomics laboratory. “As importantly, the project demonstrated the lab’s capabilities to the application of advanced genomics technology for a better understanding of biomedical problems,” he says. Additional shared core facilities soon will be available, including a vivarium for keeping and raising

research animals; a proteomics core lab to identify proteins and assist in characterization of protein modification and differential expression; a bioinformatics core to help with the application of statistics and computer science to the management of biological data; and a clinical research support core to provide protocol development, study design, monitoring and reprting of clinical studies.

Premedical students work on an experiment in the chemistry lab

January 2011 | 5


Middle East Hospital

“This robust infrastructure, supported by our strong administrative structure, facilitates the progress of all our researchers and improves their productivity and efficiency,” says Khaled Machaca, Ph.D., associate dean for research. “Shared expertise, information, and resources help us develop critical mass in research and avoid duplication of efforts; and it facilitates the transfer of knowledge and technologies to Qatar.”

investigators totaling more than $33 million. With its focus on promoting research that directly benefits Qatar, the NPRP requires 50 percent of its supported research to be conducted inside Qatar. The requirement not only ensures that the research program builds human capital in Qatar, but also helps turn Qatar into an international hub for advanced

scientific research by encouraging collaboration with research centers around the world. “Already research conducted by our investigators solely in Qatar is appearing in major international publications, providing solid evidence that our work is generating important new knowledge,” says Machaca.

WCMC-Q investigators have undertaken dozens of research studies into areas with international significance, such as cardiovascular diseases, cancer genetics, stem cell therapies, vaccine development for infectious diseases, as well as areas with local significance, such as strategies for slowing desertification, and the health effects of shisha smoking. The work has strong financial support from the Qatar National Research Fund, which has awarded grants through the National Priorities Research Program (NPRP) to WCMC-Q

Investigators in the biomedical research program focus on genetic and molecular causes of disease

January 2011 | 6


ANATOMICAL MODELS, SIMULATORS AND CHARTS FOR CLINICAL SKILLS AND TRAINING www.adam-rouilly.co.uk STAND: 7G59

SERVING MEDICAL EDUCATION WORLDWIDE


Middle East Hospital Bringing the Dalm Symposium to Qatar WCMC-Q is bringing a major international conference on diabetes and related disorders to Qatar in March with the support of Qatar Foundation and the Lorenzini Foundation in Milan, Italy. The XVII International DALM Symposium, which will be held in Doha March 14-16, will focus on the causes and treatments for diabetes, obesity and the metabolic syndrome, which have become huge public health challenges for Qatar and the Gulf Region. “The symposium is an important step in making scientific findings on the emerging pandemic more accessible to physicians and health care practitioners in the Middle East,” says Dr. Sheikh, M.D. “As Qatar’s only medical college, we welcome the opportunity to help bring scientists and physicians together to focus on a significant issue in patient care,” says Dr. Sheikh. Long-term attention to the health challenges posed by diabetes and related disorders in Qatar and the Gulf Region will be provided by a research center focused on the causes and treatments of the disorder. The Center for Diabetes, Obesity and Metabolic Syndrome will be home to a collaborative, multidisciplinary research team focused on diabetes and related endocrine, nutritional and metabolic diseases that are a leading cause of death not only in Qatar but also in the rest of the world. WCMC-Q students are encouraged to embrace the research culture throughout the medical program. Through biannual grants from the Undergraduate Research Experience Program (UREP), students conduct research under the guidance of experienced faculty members. The students have used the grants to study topics ranging from cancer diagnostics at the genetic level and the public

The class of 2010 in the Clinical Skills Center

perception of the genetic disorder Down Syndrome in Qatar to purification of drinking water and care for patients with diabetes. WCMC-Q supplements external funding with its own programs to encourage students to use their summers to participate in research in established labs in Qatar and the U.S. and present their findings to their peers upon their return. Expanding Access to Clinical Care Nearly a dozen WCMC-Q clinical faculty members provide the latest in medical care to hundreds of patients at weekly outpatient clinics held at partner hospitals in Qatar.

While most WCMC-Q physicians practice at Hamad Medical Corporation, others are credentialed to provide care at Aspetar Orthopedic Sports Medicine Hospital. “As we educate our students, we continually educate ourselves and that translates into better care for patients,” says Dr. Bakr Nour, associate dean for clinical affairs and professor of surgery who sees more than a dozen patients at his regular weekly clinic. His colleague, surgical oncologist Arash Rafii Tabrizi, M.D., has expanded the kinds of laparoscopic surgeries

January 2011 | 8


©

Vibro-Watch + Record The world’s one and only Multifunctional Vibrating Alarm Watch with recordable messages prolongs independent living at home ● ● ● ● ●

12 independent specific-time vibrating alarms 12 recordable messages for each of the specific-time selections Periodic auto-repeat vibrating alarm with recordable message Ability to select vibrating alarm with or without message No loss of programme information while changing battery

For use with: ● Dementia, Alzheimer’s, Autism, the Elderly,

People with Special Needs, Memory Loss & Diurnal Enuresis

Reminder for: ● Taking Medication, Bladder Emptying,

Timed Voiding, General Daily Routines (eating, drinking etc.), Appointments, and Behavioural Modification Programmes

Description The Malem© Vibro-Watch© + Record is a digital multifunctional watch with 12 independent specific-time vibration alarms and a specific auto-repeat vibrating alarm (range from 1 minute to 23:59 hours). Each of the selectable vibrating alarms can be accompanied with a specific recorded 10 second message. The Vibro-Watch© displays real time in hours (12/24, am/pm), minutes, seconds, month date, day of the week and also has a stop watch. Any of the set vibrating alarms can be accompanied with the recorded message. Selected specific-time or periodic auto-repeat vibration/message alarms can be easily activated or de-activated (on or off ). All programmed information is held in permanent memory so no information is lost while changing the battery.

Malem Medical 10 Willow Holt, Lowdham, Nottingham NG14 7EJ, England, UK Tel: + 44 (0)115 966 4440 Fax: + 44 (0)115 966 4672 E-mail: malem@malem.co.uk Web: www.malem.co.uk Web: www.malemmedical.co.uk © Malem Medical 2010

Model MO16


Middle East Hospital

done in Qatar, giving patients the benefit of smaller incisions and shorter recovery times. Dr Rafii Tabrizi is also working with HMC to train more physicians in the minimally invasive surgical technique. Through a recent affiliation agreement with Sidra Medical and Research Center, WCMC-Q will be the primary clinical partner for Qatar’s newest academic health center. The 450-bed hospital, which is scheduled to open in 2012, will allow WCMC-Q students to learn the best patient care, using Sidra’s advanced technologies such as robotics, computer-aided surgery and diagnostics, digital imaging and electronic patient records. WCMC-Q faculty will be involved in Sidra’s patient care, research, medical education and resident training. “Our relationship with Sidra is an essential component in the full integration of our triple mission of - excellence in education, research and clinical care,” says Dr. Sheikh.

January 2011 | 10


Middle East Hospital

Arab Health 2011 Preview The Arab Health Exhibition and Congress is one of the region's premier events for the healthcare sector. At the 2010 event, 2500 exhibitors from 60 countries showcased products and services with more than 55,000 professionals from 145 countries attending. There are expected to be around 2700 exhibitors at the 2011 event, and 30 country pavilions.

Arab Health 2010

The Dubai Health Authority (DHA) will be part of the global platform welcoming the international healthcare industry to Arab Health 2011. The UAE healthcare sector has proven robust against the global downward economic trend and the DHA is confident that the UAE’s healthcare sector will continue its growth. The healthcare market in the GCC is expected to grow at about 9 per cent annually to reach US$47 billion to US$55 billion (around Dh172 billion to Dh202 billion) by 2020, said a report by Alpen Capital. More than 200 hospital projects have been announced or are under construction with cumulative capacity of up to 27,000 beds, most of which are due to be delivered by 2015. According the report, the growth will be driven by both an increase in demand in number of treatments and the cost of health care provision per treatment. His Excellency, Qadhi Saeed Al Murooshid, Director General of the DHA, said: “Governments are faced with an increasing number of issues and demands for better healthcare from our growing populations continue within an increasingly changing economic environment. The UAE healthcare sector has proven robust against the global downward economic trend and with 200 hospital projects and 27,000

additional hospital beds expected to be delivered by 2015; the UAE’s healthcare sector will continue its growth. “As a strategic health authority, it has always been our endeavor to provide the population of Dubai with the very best quality of healthcare services and we shall adhere to our commitment to develop additional facilities,

improve the available services and to developing new focused educational events to support and expand the future of the healthcare in the UAE.” To remain certified, doctors must regularly update their skills, knowledge and practical know-how to provide the best service to their patients and to ensure their license to practise

January 2011 | 12


Middle East Hospital

Arab Health 2011 Preview

SEHA are the leading Congress supporter

does not lapse. For many in the GCC this represents a significant financial investment and time cost as only limited CME (Continuing Medical Education) accredited courses are available in the region forcing practitioners to travel abroad. Cleveland Clinic CME accredited conferences Arab Health also features the world’s largest multi-track medical congress with 18 CME-accredited conferences at which healthcare professionals can earn continuing medical education (CME) credits. The 2011 conferences will be addressed by around 500 speakers and host more than 5,500 attendees. Sponsored by the Cleveland Clinic Centre for Continuing Education, 18 conferences provide CME credits. With the launch of Arab Health 2010, IIR Middle East and the Cleveland Clinic’s Center for Continuing Education collaborated

to significantly expand continuing medical education activities in the Middle East by giving medical professionals an opportunity to gain CME accreditation by attending the multi-track conference and exhibition, reducing travel costs and time spent away from their practice. For Arab Health 2011 the number of CME- accredited conferences has been expanded to 18. Delegates who attend will receive an accreditation certificate that can be used towards maintaining their annual quota of continuing medical education credits, which are now necessary to renew medical practicing licenses in the UAE. “By ensuring that our conferences are accredited and our speakers are leading experts in their fields, IIR Middle East is committed to providing the best possible medical education available in the region,” commented Simon Page, Group Director of Life Sciences Division, IIR Middle East.

January 2011 | 13


Middle East Hospital

Exhibitor focus: Adam,Rouilly Adam,Rouilly produce a range of medical training tools from brain models and heart models to skeletons and anatomical charts; from venipuncture training tools and instruments to resuscitation simulators. These training aids help healthcare professionals perfect all manner of essential clinical and nursing skills from suturing and injection techniques through to resuscitation and airway management. This range of training simulators, combined with the finest range of anatomical models and accurate, high quality anatomical charts, make Adam,Rouilly one of the foremost names in healthcare education.

Visit Adam,Rouilly at Stand 7G 59

Adam,Rouilly sells its products to more than forty countries throughout the World. Their large range of products has been purposely designed and developed in direct response to customers' requirements and preferences. Speaking to Middle East Hospital on the subject of export sales in the Middle East, Sales and Marketing Manager Graham Fowler said, “We have a very reliable distributor network in the Middle East, which is a very important part of our export market, and has expanded considerably over the past 20 years due to the increased demand for skills training. In addition to this market there is also a requirement for anatomical models in the medical schools at the Universities. “Within the Middle East we sell into many hospitals, almost exclusively through our distributors within the various countries. We have obtained considerable business in Saudi Arabia, Iran, Yemen and Libya, although we supply most countries in the area at some time in the year. We have also secured contracts to supply Anatomical Models to the Sultan Qaboos University in Muscat and the Arabian Gulf University in Bahrain.

We have also seen a considerable increase in both enquiries and business from Iraq as the situation there improves. Hopefully this will continue to be the case.” Mr Fowler continued, “The success of Adam,Rouilly’s Export Sales is due to the hard work of our dedicated sales team. In 2009 we achieved 50%

of our total sales in export markets with significant sales in the Middle East. The advent of Clinical Skills Training in Hospitals in the Middle East is a major factor in these achievements. “Attending Arab Health since 2004 has enabled us to regularly meet many of our

January 2011 | 14


Middle East Hospital

Arab Health 2011 Preview customers, and the sales reflect the confidence our dealers have in the products, quality and service that Adam,Rouilly offers to Healthcare Education.” One of the most popular products manufactured is the Venepuncture and Infusion Arm. Cast from life, the moulding of the Infusion Arm Trainer has been improved and incorporates many new features resulting in an extremely realistic finish which shows a well developed male left arm in fine detail. The product features a closed blood system which is clean to use with reduced risk of leakage Another in demand product is the Hungry Manikin. This model was designed by two nutrition nurses at Birmingham Children’s Hospital to demonstrate to parents/carers the technique for insertion of nasogastric and gastrostomy tubes. The model features a movable epiglottis. The model enables parents/carers to visualise the correct positioning of nasogastric and gastrostomy tubes and buttons and also practise the technique. Families have reported that The Hungry Manikin gave them invaluable practice and increased their confidence and understanding. The model is supplied with a nasogastric tube in an attractive carrying case. “To simulate the look and feel of the human body Adam,Rouilly use materials which have been carefully researched and selected by our development team. We continually evaluate our models and, in cooperation with healthcare professionals and nursing specialists, develop and promote new products as medical practice advances”, says Mr Fowler. The other most popular products with Adam,Rouilly customers are the Ear Diagnostic Trainer, the Diabetic Retinopathy Trainer, and the X-Ray Positioning Doll.

The Venepuncture and Infusion Arm

Over 90 years of experience Adam,Rouilly celebrated its 90th anniversary in 2008, having first supplied natural bone material and anatomical models to hospitals and medical schools in London in 1918.

to customers throughout the world for over 75 years and have long established relationships with many world famous medical training institutions, nursing colleges, hospitals and universities.

The business rapidly expanded to all areas of Great Britain and within 6-7 years a flourishing export business was established. The first Patient Simulator (The Bedford Hospital Nurse Demonstration Doll) was manufactured in 1930 and continues to be sold to this day. The name Adam,Rouilly is recognised throughout the world by healthcare professionals for the manufacture and supply of high quality medical training aids. From its base in Sittingbourne, Kent, Adam,Rouilly have been exporting

Graham Fowler at Medica 2010

January 2011 | 15


Middle East Hospital

Healthcare in the UAE at the crossroads by Nusrate Ibrahim Manager -Transaction and Reorganisation Services, MENA Region at Deloitte Introduction Historically the UAE healthcare system has been underfunded, the expenditure on health as a percentage of GDP has been lower than in the western world; in 2007 less than 3% of GDP was allocated to health in the UAE versus 8.4% in the UK and 15.7% in the USA (WHO report – World Health Statistics 2010). It could be argued that this has been partly due to different demographics prevalent in the UAE, such as the percentage of the population over 60 years old - 2% in UAE versus 18% in the USA and 22% in the UK (WHO report – World Health Statistics 2010) as it is well known that healthcare costs have a tendency to be higher as the individual grows older and hence younger societies would require lower percentage of their GDP to be spent on healthcare. Nevertheless, underfunding was reflected in sub-optimal quality of care in the government hospitals, with low investment in medical facilities, technology, medical education and also poor governance and lack of adequate regulatory, governance and legislative frameworks. However, over the last 10 years or so, with the increase in population driven by higher life expectancy (63 years in 1970 to 78 years at present- People facts & Population Reference Bureau, World Bank) and increase in expatriate population (c.75%-80% of the UAE population), there was a realisation amongst decisions makers that the Government could no longer carry the healthcare burden on its own. It was unsustainable for the governments to provide free care for foreigners choosing to live in the UAE, particularly in a country where there is no direct taxation on the income earned by individual.

Dubai Health Care City

The above situation pre-empted the move from a government-funded healthcare model to a mixed government and private sector model. Growth in diseases of affluence The other key driver of the change in the healthcare system in the UAE is the increase in the population affected by the commonly known “diseases of affluence”. Increase in purchasing power, with GDP per capita increasing by 50% between 2004 and 2008 (IMF) plus an unhealthy lifestyle with lack of exercise have contributed to some frightening statistics: c.20% of the UAE population suffers from diabetes (www.diabetes.co.uk) and there has been increase in occurrence of cardiovascular diseases and cancers. Prosperity and wealth have not meant health! All the above factors contributed to the realization by the decision makers that the situation was unsustainable over the long term and some important changes need to be implemented at different levels in the healthcare system: regulation, funding and provision.

Despite this change and evolution not being consistent across all the emirates, and in particular between the two driving emirates- Abu Dhabi and Dubai; one common directive across the federation is that the private sector has an important role to play and the government needs to ensure its active participation to ensure the building of a sustainable quality healthcare system. Abu Dhabi Abu Dhabi has been at the forefront of changes in the healthcare system, including changes in the governance and funding of healthcare. Governance Governance-related changes have been driven to separate the role of regulator from the role of manager of hospitals. It is an accepted concept that governments’ role should be focused on monitoring and regulating the healthcare system rather than managing hospitals. With this purpose in mind, in December 2007, The Abu Dhabi Health Services Company (SEHA) was created with the responsibility for operational

January 2011 | 16


Middle East Hospital management of public hospitals and clinics in Abu Dhabi, while Health Authority Abu Dhabi (HAAD) from then on taking the responsibility solely for monitoring, regulating and enforcing of international healthcare standards for both the public and private health sector. Governments are better suited to regulate rather than manage providers This has been a step forward for strengthening the governance and the transparency of the system, thus increasing service users’ reliance on the system while simultaneously incentivizing the private sector participation in the sector. With this is in mind, Abu Dhabi started to promote partnerships with the private sector; it has subcontracted the hospital management of some large public hospitals to renowned international providers: Al Rahba Hospital, Al Corniche Hospital and Tawam Hospital are run by John Hospkins; Shaikh Kahlifa Medical City is managed by Cleveland Clinic and Al Mafraq Hospital is managed by Bumrungrad International Ltd. The establishment of Imperial College London Diabetes Centre in Abu Dhabi in 2006 was done in partnership with Mubadala Development Company. The treatment at the Centre allows the highest level of specialized patient care from diagnosis to the management of all the complications associated with diabetes. In addition Mubadala Healthcare has set up a partnership with the Cleveland clinic to develop and manage a 360-bed state of the art hospital – the Cleveland Clinc Abu Dhabi (USD 1.9 billion). The hospital is scheduled to open in late 2012 and it is planned to be served by Western-trained, North American board-certified (or equivalent).

Funding In Abu Dhabi, Health insurance requirement was introduced in 2006, and since 2007 all expatriates residing in Abu Dhabi had to have health insurance provided by their employer or sponsor. The law requires the employers to enroll their expatriate workforce into a scheme known as Daman, which is run with Munich re, a German insurer. There are over 30 insurers in Abu Dhabi; however most of them are focused on the premium market, while Daman caters for the “basic” level cover in addition to the premium cover. UAE nationals enjoy free healthcare services under a separate insurance scheme known as thiqa insurance scheme; thiqa members have access to over 1600 providers, including both public and private. Abu Dhabi: the way forward HAAD has a strategic plan for 2010-2104, with very specific priorities: 1. Fill critical gaps in capacity and insurance coverage 2. Improve medical outcomes 3. Inspect and control for quality 4. Improve health professional education 5. Increase emiratization of health sector 6. Improve public health 7. Create customer transparency

8. Pay-for-quality 9. Increase private sector investment 10. Be prepared for emergencies 11. Automate internal processes 12. Develop quality workforce and plan succession The above priorities reflect a commitment by the Government of Abu Dhabi to drive forward the changes that have already been started to be implemented in the healthcare system. In my opinion, it also reflects that there has been an assessment of “problem’ areas where more work needs to be done, particularly around strengthening the governance, measuring medical outcomes and linking pay for procedures with quality. Challenges However for this vision to materialise, there are some specific external factors which are going to play an important role: 1-The ability to train and attract quality medical staff and then to retain 2- Mass of service users/patients (demand) 3- Ability to attract inward medical tourism 4- Set up a quality brand associated with Abu Dhabi providers that convinces both nationals and expats not to go abroad for treatment.

January 2011 | 17


Middle East Hospital Healthcare in the UAE at the crossroads cont:

to attract medical tourism both from the region and from other parts of the globe. The aim is to reverse the trend of outward medical tourism affecting the UAE, where the Government spends c. USD 2 billion a year treating nationals abroad. Despite the current construction delays, the DHCC has already attracted some renowned providers in the city including: Harvard Medical School University Hospital, Great Ormond Street Hospital, and American University of Beirut Medical Centre. DHCC on its completion is expected to have 17 hospitals with 2,325 new beds with the aim of treating UAE residents plus attracting medical tourists. DuBiotech (free zone), Middle East’s first Science and Business Park dedicated to global Life Science has already started to attract a number of Biotechnology, Pharmaceutical & Research companies including global leaders like Pfizer, Johnson and Johnson, Amgen, Merck Serono and Genzyme. However, the recovery of the economy will dictate the progress of these two major projects. The consensus across the broad spectrum is that the vision of making Dubai a preferred healthcare destination is not in question, the question is the timing when this vision is going to transform into reality.

Dubiotech HQ

Certainly the Abu Dhabi government has already made significant progress in setting up a funding / insurance system; however the key challenge will be to ensure sufficient demand in all the newly built hospitals that ensures their long term sustainability. Dubai – Planned healthcare initiatives and reforms in Dubai Dubai healthcare reforms have been affected by the unfolding of the 2008 credit crisis which had an

adverse impact across the economy, in particular in the real estate sector with some projects being shelved while others were delayed. Dubai Health Care City (DHCC) and Dubai Biotechnology and Research Park (Dubiotech) DHCC free zone (a USD 3 billion development) was created to promote private investment in healthcare; to provide high quality healthcare to the residents in the UAE and

Governance Comparatively to Abu Dhabi, Dubai is running behind the healthcare reforms and it could be argued that there is not yet a clear distinction between the regulator and the provider. The Dubai Health Authority is the regulator of the healthcare in Dubai and it is also a provider of healthcare facilities through the DHA healthcare facilities, including Rashid Hospital, Dubai Hospital, Al Wasl Hospital. On the other hand, the Centre for Healthcare Planning

January 2011 | 18


Middle East Hospital About the author Nusrate is a Graduate in Economics (University of Leicester, 1992), a Qualified Accountant (FCCA- Fellow of Association of Chartered Certified Accountants, 2003) and is also a Member of the Chartered Institute for Securities & Investment (CISI) in London.

SEHA stand at Arab Health

and Quality (DHCC) is responsible for regulating the healthcare institutions inside the DHHC. One of the key focuses of the DHA has been to establish laws demanding international accreditation mandatory for all healthcare facilities. Funding Unlike Abu Dhabi, there is no compulsory healthcare insurance requirement in Dubai requiring employers to cover expat workers. However, this is not due to the lack of commitment for such a move from the Government but just a time lag driven by the credit crisis.

Practices will be the key drivers of the new system and will be responsible for the management of patient care. Every resident will have to register with a public or private outpatient clinic General Practitioner); they will then be issued a health card which will give them access to essential healthcare within Dubai only. The planned Dubai health funding system even though similar to the Abu Dhabi system, has some key differences:

The scheme was originally planned to be operational from January 2009, however due to the financial challenges faced by the Emirate, its introduction has been delayed as the Government could not afford to add to the already struggling private sector an additional overhead. Once the plan becomes effective, it will be mandatory for every resident in Dubai to be part of the health funding system.

1. Abu Dhabi system requires the employer/sponsor to provide health insurance coverage for the employee and family, while under the Dubai insurance scheme the employee will have the choice of offering cover to the employee only 2. The requirement for the residents to register with a General Practitioner and hence driving the setting up of a potential referral system (based on the UK model) 3. Nationals will have access to free care but that would only be in public hospitals.

Operation of the Plan The new system will require employers to contribute the majority of the funding through a flat rate to the Health Benefits Contribution (HBC) pool, paid on behalf of their employees. Outpatient Care

The original timings were for the DHA transition programme to be completed by 2012 (under the original assumption that it would have started in January 2009) and for the DHA health funding process fully implemented by 2015.

She achieved an Islamic Finance Qualification (IFQ) with the Chartered Institute for Securities & Investment in London in 2009. Her key professional assignments have focused on business planning and performance analysis, strategy evaluation and assessment of risks and controls and have included both Private and Public Sector Organisations. Nusrate joined the Professional Services firm Deloitte in the UAE in March 2010 and since then has been involved in diverse projects in the Gulf. Final thoughts In December, I had the opportunity to attend the World Healthcare Congress in Abu Dhabi and I was encouraged by the determination of the UAE to establish itself as a reputable healthcare destination; its pride in the developments already in place and its continued efforts to ensure that the momentum was not lost. I do believe in the potential for the development of a sustainable healthcare system in the UAE, despite the current inconsistency between the stages of growth in the two key Emirates’ healthcare systems. However, I do think that the successful accomplishment of the vision of making UAE an inbound tourism destination will require a more concerted and coordinated effort across the emirates to ensure the buildup of enough demand, which is a key driver for attracting good quality physicians and retaining them for the long term.

January 2011 | 20


Middle East Hospital

Exhibitor focus: Malem Medical For 30 years Malem Medical have been manufacturing the world’s best and largest range of Enuresis Alarms and Vibrating Watches for the treatment and permanent cure of Nocturnal as well as Diurnal Enuresis. Malem Enuresis Alarms (bedwetting alarms) are designed to maximize success in the treatment and cure of bedwetting and provide a safe, efficient, economical and permanent cure for bedwetting in contrast to the short term relief offered by expensive and potentially dangerous drugs. Asked about Malem’s hopes for Arab Health this year Dr Hilal Malem told MEH, “Our main aim in being at Arab Health is to find local distributors for our products. Our world famous Enuresis Alarms offer the only safe, reliable, tried and test method for the treatment and permanent cure of bedwetting at an economical cost. Drugs, in the form of antidiuretic hormone, if they work at all, provide a temporary reduction in the quantity and frequency of bedwetting as long as the child is receiving the drug. This could be for years at a vast monthly cost that can be twice the cost of one of our enuresis alarms. “Wih our latest Universal Wireless alarm you can use up to seven transmitters, each one of them can be attached to a different sensor (such as Enuresis body worn Sensor; Bed-Mat Enuresis Sensor; Pressure-Mat; and Pressure Release Mat) to help detect patient movement and prevent dangerous falling or unauthorised wondering. One small battery operated receiver that can be carried by the carer will communicate with up to seven Transmitters. This Universal wireless product is ideal for nursing/care homes, or for use at home.”

The Talking Vibro-Watch

Another exciting product is the Talking Vibro-Watch. You can programme this watch for up to twelve (12) specific times and record a unique message for each time so that the user will be reminded at the correct time with Vibration and a dedicated message that will be announced. The Malem Bedwetting Alarm consists of a safe electronic device contained in a small, ultra lightweight plastic box which is comfortably and discreetly worn on the nightwear top close to the collar bone. The alarm is connected to a sensor which detects urination. When urination commences and the sensor is moistened, the alarm is triggered and a stimulus is activated. This can be in the form of a loud sound, vibration or light. The Easy-Clip, Standard or Bed-Mat sensors can all be linked to any of the alarms. Repetitive awakening by the Alarm as soon as urination commences will gradually train the brain to exert automatic control over the bladder. Eventually, the bedwetter will either

wake up before urination or be cured resulting in them sleeping throughout the night without needing to empty the bladder. This form of treatment has proved to be the safest, most reliable and economical way of curing bedwetting with over 90% success within a few weeks and has no side effects. Dr Malem explains, “Bedwetting, or nocturnal enuresis, is a very common but secret problem. It is very distressing and deserves to be treated. It can affect anyone and as many as 10% of 5 year olds, 5% of 10 year olds and 2% of adults suffer unnecessarily. As many as 40% of the elderly may also suffer from incontinence.” Malem Medical sell their products all over the world. In the UK the company has won the NHS Supply Chain contract for supply to the NHS, giving them almost 100% of the UK market. They have achieved around 80% of the market share in the US, and are well established in Europe, Japan, Brazil and Korea.

January 2011 | 22


Middle East Hospital

Arab Health 2011 Preview

Malem Medical stand at Arab Health 2010

The Universal Wireless Alarm

Visit Malem Medical at Stand 7H 58

January 2011 | 23


Middle East Hospital

SAUDI MEDICARE 2011: Preview Saudi Medicare 2011‌ Your Gateway to a US$ 16.3 Billion Healthcare Market

April 10-13 2011 at the Riyadh International Exhibition Center

Ranking second in appropriations after education, the Saudi healthcare sector had US$ 16.3 billion to spend during 2010 on the development of numerous projects that include: - Hundreds of new primary care centers throughout the Kingdom. - 92 new hospitals with a capacity of 17,150 beds - Three teaching hospitals within university campuses with a total capacity of 1800 beds. - Various hospitals and medical science colleges in all three provinces. Pharmaceutical and healthcare spending in Saudi Arabia is expected to increase from US$ 9.94 billion in 2008 to US$ 18.09 billion by 2013, driven by the growing healthcare demand of the country's sizeable and relatively wealthy population. The positive growth trend reinforces the country's reputation as a key stakeholder in the regional healthcare industry as Saudi's drug market already accounts for a dominating 65 per cent of all pharmaceutical sales in the GCC. Saudi Arabia's pharmaceutical and medical device markets, in particular, are expected to grow at a compound annual growth rate of 12% and 7% respectively until 2012. This growth is influenced in part by aggressive government spending as US$ 16.3 billion has already been allocated for healthcare expenditure, representing a 17% increase from 2009, for various large-scale projects including new primary centres all over the country and 92 new hospitals with a combined capacity of 17,150 beds. The robust outlook of the country's healthcare and pharmaceutical sectors is evident in the upcoming 'Saudi

Medicare 2011 – The 14th International Healthcare, Hospital Supplies and Medical Equipment Show', which will be held from April 10 to 13, 2011 at the Riyadh International Exhibition Center. Saudi Medicare 2011 has registered a 30% increase in exhibition area to accommodate a significant rise in exhibitors and trade visitors, including a growing number of corporate decision makers of healthcare multinationals and foreign investors.

Demand for pharmaceutical products as well as medical supplies and related services has picked up on account of the Saudi Government's efforts to strengthen the country's ability to provide world-class healthcare to its citizens and residents. The government has even increased healthcare expenditure this year to ensure that upgrade programs are implemented immediately. Global and regional companies have

January 2011 | 24


Middle East Hospital “The substantial growth in the Saudi healthcare sector is unmatched anywhere else in the Gulf region and across the entire Middle East. The Saudi government has set ambitious goals to trigger massive development of the sector by large budget allocations that reached $US 16.3 billion in 2010. The 9th five year plan announced by the Saudi Council of Ministers last August, and which includes infrastructure and welfare projects valued at US$ 385 billion planned for the period 2010 – 2014, calls for the construction of 117 new hospitals including 32 specialist ones with a total capacity of 22,372 beds. The plan also calls for the construction of 750 primary care centers and 400 first aid centers during that period.” “We strongly believe that Saudi Medicare 2011 will be an exceptionally important edition for all international manufacturers and suppliers of healthcare technologies and medical equipment and supplies and an ideal platform to tap into this lucrative and dynamic market. The full support Saudi Medicare enjoys from the Saudi Ministry of Health, adds further assurance that the show will be attended at the highest level by top industry professionals and public healthcare authorities in the Kingdom” Fadi Kaddoura, Group Vice President, IFP Group / Riyadh responded promptly as manifested by the significant increase in the number of exhibitors who are on the lookout for lucrative business and investment opportunities in the country. Saudi Medicare has further revealed that it expects 2011 to serve as a starting point of a new era of growth in the country's healthcare industry with new business opportunities emerging in

Jonathan Richards CEO of Medibord meets Abdullah Al Thari Saudi Ministry of Health – Director of Equipment & Supplies Directorate and Fadi Kaddoura VP Riyadh Exhibitions

Abdullah Al Thari of the Saudi Ministry of Health (Director of Equipment & Supplies Directorate), and Fadi Kaddoura, (Group Vice President, IFP Group / Riyadh Exhibitions Co.) visited the Medica trade fair in Dusseldorf to introduce the upcoming Saudi Medicare 2011 trade show to the global healthcare community. During their visit to Medica Mr Al Thari and Mr Kaddoura officially announced the opening of nominations for the Middle East Hospital Health and Innovation 2010 awards, with the winners to be presented with their awards at Saudi Medicare by the Saudi Minister of Health, Dr. Abdullah bin Abdul Aziz Al Rabeeah. The distinguished visitors also visited the UK Pavilion and met exhibitors looking to export to the booming Saudi healthcare market. medical devices and supplies, generic pharmaceuticals, healthcare insurance and education. Saudi Medicare also noted a huge potential in the relatively new area of e-health, which has received a major boost with the government's efforts to establish a national electronic record system for healthcare. Held concurrently with SAUDI MEDICARE 2011 are SAUDI DENTISTRY, SAUDI EYECARE and SAUDI LAB 2011. This 4 in 1 show will facilitate direct access to key government officials, healthcare sector market leaders, investors, importers, and fellow professionals. Such an

invaluable exposure will undoubtedly help you in establishing a foothold in this vibrant market and will enable you to present your products, technologies, and services to a highly professional audience eager to examine the latest medical innovations. Saudi Medicare 2011 will be held as well in conjunction with the 5th Medical Devices Scientific Forum, which is organised in cooperation with the Saudi Food and Drug Authority. The scientific forum will discuss various topical medical issues, including those related to medical devices technology, its management, and the challenges being faced in this field of expertise. www.recexpo.com

January 2011 | 25


Middle East Hospital

Dr Abdulrahman Al Mishari Hospital

For 24 years Dr. Abdulrahman Al Mishari Hospital has been providing high quality of Medical Care to its patients. It has dedicated its time to ensure that an evidence based standard of Health Care is achieved and rendered to our patients and their families.

installed a state of the art, 16 proslice CT Scanner. The new scanner enables enhanced cardiac and paediatric scanning services. It also houses a static MRI Unit, a much prized clinical development.»

The hospital strives to protect and continuously improve the environment, by maintaining a care management procedure prepared for any situation that may affect the residents of our Community. The hospital is a Private General Hospital comprising of 122 beds.

Asked about international recognition Mr Al Mishari said, «We are very pleased to inform you that after all the hard work and efforts of our beloved staff, in July 2010 Dr. Abdulrahman Al-Mishari Hospital has passed the Re-Accreditation Process and received the highest award – Diamond Accreditation by the Accreditation Canada.

Mohammed Al Mishari, Vice President of the hospital spoke to MEH about the hospital and its facilities, «The ARMH recently

«Dr. Abdulrahman Al-Mishari Hospital is the first hospital in the Middle East who had been accredited by the Accreditation

Canada, new International Program.

Qmentum

«The organization received “Qmentum International of Accreditation Canada” for focusing on the achievement of quality, by monitoring outcomes, by using evidence, by working on the best practice to improve services, and by benchmarking with peer organizations to drive system-level improvements». In further recognition of its achievements the hospital has now been nominated for an MEH award for oustanding services to healthcare in the Middle East. Looking ahead to the future Mr Al Mishari said, «We are currently gathering information from the

January 2011 | 26


Middle East Hospital community and the public during the next few months and then plan to release a strategic plan for a 5year period starting next year. «Despite the global slowdown, Saudi Healthcare industry is booming, as well as the Health Insurance industry. We do have plans for domestic expansion, and God willing, to go international in the near future.» History of the hospital It was in 1972 that the young Abdulrahman fulfilled his one big dream. He graduated and became the very first physician from the eastern province. He became the first Saudi Member of the Royal College of Obstetrics and Gynaecology in London. Upon returning home, the Saudi government recognized and honored Dr. Mishari for his achievements. They saw in him the capability to run and supervise the construction of the very first College of Medicine in the Kingdom of Saudi Arabia intended to cater to the educational and professional needs of the young nation. It was in 1980 that Dr. Abdulrahman Al Mishari was appointed Deputy Manager and Head of the Gynaecology Department in King Khaled University Hospital. As the Kingdom was developing rapidly, the University Hospital and Medical School was set for massive expansion and the responsibility as Project Manager to oversee the design and construction of the College of Medicine was given to Dr. Mishari. Under his leadership, a modern school for College of Medicine was built and more than 500 Saudi nationals graduated and became new doctors. After long years of a dedicated teaching career, Dr. Mishari decided to pursue his other dream – contribute to the development & infrastructure of the fast growing economy, by establishing a private hospital. In Year 1987, the Hospital was inaugurated with the Governor

of Riyadh Region, His Royal Highness Prince Salman Bin Abdulaziz Al Saud, doing the honor of cutting the ribbon. Today, together with his children, Hadeel and Mohammed, Dr. Abdulrahman Al

Mishari’s journey continues. Their quest for quality and service excellence is relentless, through good leadership and passion for quality. appt@al-mishari.com.sa

January 2011 | 27


Middle East Hospital

MEH 2010 Health and Innovation Awards Since the opening of nominations for our 2010 Healthcare and Innovation Awards for exporters of medical equipment to the Middle East, and healthcare providers, there has been a high number of applications from companies and healthcare providers from all areas of the industry. The awards are now in their second year, as is the magazine. The 2009 awards were presented at Arab Health 2010 by Lord Darzi, the distinguished surgeon and UK business ambassador. This year, in recognition of the importance of the Saudi Arabian healthcare market to exporters to the region (the largest market in the Middle East) the winners will be presented with their awards at Saudi Medicare 2011 by the Saudi Health Minister. Also, at Arab Health 2011 Lord Darzi will present official nominations to some of the UK-based nominees. The awards categories cover manufacturers and providers of hospital equipment, nursing equipment, respiratory devices, preventative solutions, surgical equipment, and more. New products for export to the Middle

East are being recognized, as well as established products that have already made a significant contribution to healthcare in the region. There is also a section for the best exporters from the most prolific exporting regions and countries, and awards for hospitals, companies or individuals that have made outstanding contributions to healthcare in the Middle East region with awards for excellence in pediatric care, cardiovascular care, orthopedic care, rehabilitative care, respiratory care, cancer care, healthcare recruitment, and healthcare research. These awards are intended to recognise the contribution of companies from across the globe to healthcare services in the Middle East, and the benefits their products have provided for hospitals, clinicians and patients in the region.

played a major role in the ongoing revolution in healthcare provision taking place in the Middle East.

The Arab countries import the vast majority of their medical devices and healthcare products, and the introduction of high quality, innovative new technologies to these countries by medical equipment manufacturers has

Nominations must be completed by 28 February 2011. Please visit the MEH website www.middleeasthospital.com to find out how to put your product, company, or organisation forward for an award.

Lord Darzi (left) with Adrian Cossor of AC Cossor at Medica. Lord Darzi will present UK companies with MEH award nominations on 24th January at 5pm in the Novotel at Arab Health 2011

lth and Inn Hea o 10

MEH

n tio va

Medibord Ltd have launched the world’s first fully x-ray translucent and nonconductive material for a range of couch tops and patient positioning devices. Medibord™ is a unique and innovative MRI, CT and radiotherapy compatible material. Unlike carbon fibre alternatives, Medibord has been designed to be fully x-ray translucent and non-conductive ensuring no heating occurs with MRI giving no artefacts and enabling accurate software image overlay. Successful clinical trials carried out by the British Healthcare Service at the Nottingham University Hospitals have proved the Medibord™ to be a revolutionary material for the use in radiotherapy and MRI scans and treatment.

20

Most innovative product for export: diagnostic category Medibord Limited for the Medibord MRI, CT and radiotherapy compatible material

Official Nominee for 2010 Awards

January 2011 | 28


Middle East Hospital

lth and Inn Hea o 10

MEH

n tio va

20

Outstanding contribution to healthcare in the Middle East: educational category Adam, Rouilly for the Hungry Manikin

OfďŹ cial Nominee for 2010 Awards

Adam, Rouilly produce a range of medical training tools from brain models and heart models to skeletons and anatomical charts; from venipuncture training tools and instruments to resuscitation simulators. These training aids help healthcare professionals perfect all manner of essential clinical and nursing skills from suturing and injection techniques through to resuscitation and airway management. This range of training simulators, combined with the finest range of anatomical models and accurate, high quality anatomical charts, make Adam, Rouilly one of the foremost names in healthcare education.

lth and Inn Hea o 10

MEH OfďŹ cial Nominee for 2010 Awards

For 30 years Malem Medical have been manufacturing the world’s best and largest range of Enuresis Alarms and Vibrating Watches for the treatment and permanent cure of Nocturnal as well as Diurnal Enuresis. Malem Enuresis Alarms (bedwetting alarms) are designed to maximize success in the treatment and cure of bedwetting and provide a safe, efficient,

Award for excellence in respiratory care Michael Oko Michael Oko is a dedicated ENT (Ear, Nose & Throat) Consultant surgeon with a special interest in both sleep apnoea and snoring, campaigning for better research and facilities for sufferers of these conditions, including the risks associated with undiagnosed sleep apnoea.

n tio va

20

Most innovative product for export: nursing category Malem Medical for the Universal Wireless Alarm

economical and permanent cure for bedwetting in contrast to the short term relief offered by expensive and potentially dangerous drugs. With the new Universal Wireless alarm you can use up to seven transmitters, each one of them can be attached to a different sensor to help detect patient movement and prevent dangerous falling or unauthorised wondering. This product is ideal for nursing/care homes, or for use at home.

In 2005 Mr. Oko was appointed as a consultant surgeon for ENT for the United Lincolnshire Hospitals Trust, and then as the Clinical Lead (head of department) in 2007. This led him to set up the sleep service within the Lincolnshire County, ensuring that people within the area had access to such a necessary facility that was previously lacking. In 2006 Michael Oko founded the Snoring Disorders Centre to develop exceptional s e r v i c e s t o pat i ent s f or t he diagnosis and treatment of obstructive sleep apnoea.

January 2011 | 29


Middle East Hospital

lth and Inn Hea o 10

MEH

n tio va

20

Most innovative product for export: preventative category Bedfont Scientific for the NObreath FENO monitor

Official Nominee for 2010 Awards

Established in 1976, Bedfont Scientific Limited specialises in the manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets throughout the world. Applications include carbon monoxide monitors for use in smoking cessation programmes (Smokerlyzer®) and by the emergency services for carbon monoxide poisoning (toxCO™); fractional exhaled nitric oxide (FENO) detection to provide accurate analysis of airway inflammation (NObreath®), breath hydrogen monitoring to aid the detection of gastrointestinal disorders (Gastro+ Gastrolyzer®) and a medical gas delivery system used in inhaled nitric oxide therapy for hypoxic neonates and pulmonary hypertension (NOxBOX®).

Durbin PLC is a specialist medical supply company that sources and distributes medical equipment, pharmaceuticals and consumable supplies to healthcare professionals in over 180 countries. Established in 1963 in London and with an expected turnover in excess of £40m this year, they have set up their operation to act as a one-stop-shop able to deal with healthcare supply needs from local project level to national scale projects. In addition to the export business, they have divisions that handle clinical trial supplies, imported medicines, and family planning supplies. They also handle storage and distribution for a number of third-parties.

lth and Inn Hea o 10

MEH

Outstanding contribution to healthcare in the Middle East: ancillary category TTC Language Services Ltd for Pharmaceutical translation services

n tio va

Nominee for British-Middle East exporter of the year 2010 Durbin PLC

20

Bedfont also strives to produce high quality consumables at the lowest possible prices; these include disposable cardboard mouthpieces, infection control filters, non-alcohol wipes and calibration gas for all their monitors.

Official Nominee for 2010 Awards

TTC provides pharmaceutical translations by specialised translators who have experience working with the pharmaceutical industry. Currently, TTC provides translation services for suppliers of turnkey pharmaceutical plants; machinery and equipment for the treatment of pharmaceutical raw materials; analytical instruments and lab reagents; testing instruments; active pharmaceutical ingredients; tableting and capsulation unit. TTC are equipped with 16 years of experience in the fields of translation and localisation, a solid infrastructure of providing comprehensive language services and most importantly a clear vision. They have now proved themselves as a leading language services provider for both online and offline media and for local and global requirements.

January 2011 | 30


MEH

n tio va

20

lth and Inn Hea o 10

Official Nominee for 2010 Awards

For For 24 years years Dr. Dr. Abdulrahman Al Mishar Misharii Hospital has been providing providing high quality of Medical Car Caree to its patients. MISSION STATEMENT Dr. Abdul Rahman Al-Mishari Hospital is committed to Superior Quality and Safety in meeting the Health care needs of the clients we serve by Fostering Advanced and Compassionate Health care Services. VISION STATEMENT We shall treat each patient like a member of our own family thus providing Superior Quality Health care Services and to be recognized as the center of excellence in the Management of Obstetrics, Gynecology and Pediatrics in the Central Region of Kingdom of Saudi Arabia.

www.drabdulrahmanalmishari.com.sa


Mention code: MH-HI and save 15% off of regular fee.

-DQXDU\‡'XEDL,QWHUQDWLRQDO&RQYHQWLRQDQG([KLELWLRQ&HQWUH        

7KH6th Healthcare 7KH6th H Insurance Forum aims to provide provide VWDNHKROGHUVLQWKHKHDOWKFDUHLQVXUDQFHLQGXVWU\ZLWKWKH VWDNHKROGHUVLQWKHKHDOWKFDUHLQVXUDQFHLQGXVWU\ZLWKWKH healthcare insurance latest updates and insights into healthcare UHJXODWLRQLQWKH*&&DQGZLOODOVRFRYHUDP\ULDGRILVVXHV UHJXODWLRQLQWKH*&&DQGZLOODOVRFRYHUDP\ULDGRILVVXHV LLQFOXGLQJLQVLJKWVLQWRKRZPDMRULQVXUHUVDUHH[SORLWLQJWKH QFOXGLQJLQVLJKWVLQWRKRZPDMRULQVXUHUVDUHH[SORLWLQJWKH ead of compulsory healthcar e insurance around around the spr spread healthcare om international international healthcare healthcare rreason, eason, and case studies fr from insurance markets.

Key Contributions From: Dr. Ajit Nagpal, Former Advisor Health Policy and Hospital Affairs, Ministry of Health, UAE

Dr. Michael Bitzer, CEO, National Health Insurance Company, Daman

Dr. Finn Goldner, Manager Health Insurance Regulation, Health Authority Abu Dhabi

Dr. Philipp Vetter, Head of Strategy, Health Authority Abu Dhabi Dr. Haidar Al Yousuf, Director of the Funding Department, Dubai Health Authority

Topics being discussed include:            ‡$QXSGDWHRIWKHFXUUHQWVWDWXVRIWKHKHDOWKFDUHLQVXUDQFH market in the GCC         ‡7UHQGVLQVLJKWVDQGSHUVSHFWLYHVRQKHDOWKLQVXUDQFH     ÀQDQFLQJLQWKH*&&       ‡,QVLJKWVLQWRHFODLPVDQGEHWWHUSULFLQJ          ‡$VVHVVLQJWKHHIIHFWRIH[LVWLQJUHJXODWRU\IUDPHZRUNVRQ stakeholders

www.iirme.com/healthcareinsurance


Middle East Hospital

Outstanding contribution to healthcare in the Middle East: surgical category Bolton Surgical for their range of surgical instruments

MEH

20

lth and Inn Hea o 10

n tio va

Bolton Surgical Ltd is a manufacturer and supplier of the finest quality Surgical Instruments and accessories for use within the modern theatre environment. The company has a large customer base of both NHS and private sector hospitals, clinics, and Decontamination Units throughout the UK.

Official Nominee for 2010 Awards

Bolton bring together traditional manufacturing methods with the technology you would expect from a market leader in Surgical Instrument supply, enabling them to provide a totally flexible service tailored to meet the differing and demanding needs of modern Theatre/Decontamination Departments.

2010 German-Middle East expoter of the year TRUMPF Medical Systems

The TRUMPF Group has its headquarters in Ditzingen, located near Stuttgart, Germany.

Olberon Medical Innovations Limited, is a privately-owned UK company, based at the University Of Nottingham Institute for Enterprise and Innovation Lab. As a start-up company, Olberon was formed in Summer 2005, in order to develop and commercialise innovative medical devices concepts that originated from direct experience of patient care, where the need is clearly identified and the solution’s intellectual property rights are closely protected. Pivotal to Olberon is its I.P., and the experience of its management team.

lth and Inn Hea o 10

n tio va

Most innovative product for export: nursing category Olberon for the Vacuderm cannulation dressing

20

In all business areas, innovations from TRUMPF are setting new trends and they are establishing

new technical standards. The company's innovative strength is derived from high ex¬penditures on research and development, which is 9.7 percent of sales (fiscal year 2009/10).

MEH

The goal of TRUMPF Medical Systems is to improve processes in clinics and to make working conditions there more ergonomic. TRUMPF offers operating tables, surgical lights and ceiling-mounted equipment management systems.

Official Nominee for 2010 Awards

Vacuderm is a cannulation dressing with a disposable vein inflation aid attached to distend the vein prior to needle insertion, ideal for known problem patient groups such as paediatrics, obese, illegal drug users, chemotherapy patients etc. and for improving cannulation success in general.

January 2011 | 32


Middle East Hospital

Arab Health 2011 Preview: UK Pavilion UK strengthens its commitment to the UAE With the UK famous internationally for its world leading, dependable and top quality healthcare products, Arab Health 2011 will be a busy four days for over two hundred British companies travelling to the event. The UK’s interest in international trade is at an all time high, and Arab Health allows companies to explore exciting export opportunities and showcase their world leading technologies on a global stage. Home to world class scientific excellence and innovation, the UK continues to be committed to transforming healthcare delivery through investment in science and technology. The UK already enjoys an excellent relationship across the Middle East, with British companies supporting UAE health delivery reforms by offering a wide range of first rate medical technologies and medicines. For this reason, it is no surprise that the UK’s presence at Arab Health is considerable and growing each year exploring export opportunities on an international stage. RD Biomed will be at the show to launch their product Peptest™ a revolutionary diagnostic device that detects reflux disease more quickly and easily by measuring the level of pepsin in clinical samples . Single Use Surgical will also travel to the event to speak to potential partners from across the UAE on their single use instruments. Promoting the concept of ‘day surgery’ in the Middle East, Anetic Aid will be at the show to explain how modernising approaches to surgical procedures can reduce waiting times, improve cost efficiency and make health services more patient-centred. Recently awarded The Queen’s Award for their innovative

Paxman cooling system

JRI Ltd hips and shoulders

orthopaedic products, JRI Ltd is travelling to Arab Health next month to offer their surgical solutions to a worldwide audience; showcasing their range of primary and revision hips and shoulders.

huge problems with sample specimen collection and point of care testing, Brenmoor Ltd offer a solution to this global problem with their printed wristbands and identification scanner and printer.

Offering their pressure relieving and pressure reducing equipment to the Middle East, Park House Healthcare will be at the show providing their innovative solutions in pressure area care, postural management and moving and handling and act as a launch pad for their lightweight, durable, easy to manoeuvre aluminium hoists.

Merlin Medical is also travelling to Dubai to seek new business partners from across the UAE. As a one-stop-shop of cutting edge innovations, including manual resuscitators, infection control products and medical supplies for the emergency services.

Inditherm plc is at the show to unveil their safe and practical solution for nursing new born babies across the region. CosyCrib provides the perfect environment to keep new born infants warm and content during their stay in hospital.

A world leader in assistive technologies and offer an extensive range of innovative mobility products, Drive Medical will be at the show with examples of their wheelchairs, mobility scooters, powerchairs, daily living aids and rise and recline armchairs.

Showcasing their range of vitamins at the show Principle Healthcare is one of the UKs leading vitamin, minerals and supplements producers and are hoping to meet distributors from across the world.

All of the examples above highlight the outstanding standard of UK innovation and in these globally testing times, it is vital that companies keep striving for the latest advances in technology and patient care.

Every day thousands of patient’s samples are lost, mislay or mixed up due to human hand writing errors – an issue that is causing

For more information on any of the companies visit them in Hall 7 stand D37 or contact Victoria Haley at v.haley@medilink.co.uk

January 2011 | 33


Middle East Hospital

Exhibitor focus: Mirage Health Group Mirage, as a brand, has been representing high quality medical and dental innovations for over 15 years and was subject to an MBO in 2003 by current Managing Director Jeremy Bishop. The Group is comprised of Mirage Medex, and its dental arm, Mirage Dental Products Ltd. Mirage Medex specialises in the provision of ear care products which allow clinicians to carry out safe and effective ear care in accordance with today's UK guidelines in primary care and ENT settings. The unique Propulse ear irrigation range has been supplied to the UK primary care market since 1997. Mirage also exports its range of products to Europe, South Africa, Australia, and the United States. The Propulse Ear Irrigator has been the clinicians choice for over 10 years. Over that time, the market leading Propulse range of products has developed to include good value, high quality instruments designed specifically for ear care. The current range includes the Propulse NG Ear Irrigator that utilises Propulse Single Use QrX Tips (to help minimise the risk of cross infection between patients). Propulse Cleaning Tablets ensure that the cleaning of the Propulse Ear Irrigator is a simple and effective procedure. The Propulse NG was launched in January 09 and encompassed focus group and user feedback culminating in the most up to date, user and patient friendly Ear Irrigator to date. David Caldwell, General Manager – Sales and Operations, told Middle East Hospital, “Mirage Medex is committed to continually working with clinicians to provide the tools they need to carry out safe and

The Propulse ProScoop

succesful ear care for patients. We have strong links with the various UK bodies responsible for carrying out nurse ear care training and issuing UK guidelines and protocols. We use this as a route to continually gain feedback from users of our products. In addition we carried out a national ear care survey in 2007, targeting every surgery in the UK to identify trends in ear care and areas for future development, which culminated in the January 09 launch of the Propulse NG.” In 2009 the Propulse NG, the latest in an impressive range of ear care products from Mirage Health Group, won a Middle East Hospital

Health and Innovation Award in the Most Innovative Preventative Technology Product for Export category. The Propulse NG Irrigation System The Propulse® NG sets new standards in ear irrigation. Its patented and unique features create an irrigation system that is safe, convenient and patient friendly. The Propulse®NG Irrigation System is both portable and rechargeable making it ideal for domiciliary visits or in areas without an electricity supply. Its variable pressure delivery system provides a pulsed water jet, which is easily controlled.

January 2011 | 34


The Propulse® NG Electronic Ear Irrigator

The Propulse® NG Electronic Ear Irrigator is now supplied with the all new, patented Quick Release Handle and QrX™ Single-Use Tips. The QrX™ system locks the tip into place during use, making this the most operator- friendly Propulse® to date. The operation of the Propulse® NG is controlled by the convenient footswitch, allowing the machine to be controlled by the foot, leaving both hands free for treatment of the ear. A full range of accessories and consumable items such as Single Use QrX™ Tips and

Propulse Cleaning Tablets is available for use with the Propulse NG. The Propulse NG is a class IIa Medical device manufactured in accordance with the Medical Device Directive 93/42/EEC and is CE marked for safety. New products being launched at Arab Health Joining the ever expanding Propulse® family of ear care products Mirage Health Group are pleased to launch the Propulse® ProScoop and the Propulse® ProTect Shoulder Cape, with deliveries commencing January 2011. Designed specifically for the removal of ear wax and not an adapted surgical instrument, the ProScoop is single use, for reduced risk of infection. A Mirage spokesman says, “The benefits for distributors of both new products is that the Propulse® brand is synonymous with quality ear care products, and Mirage is running advertising campaign from November 2010 to January 2011 targeting practice nurses, creating new product awareness. “The ProTect’s 3 ply design

combines a super absorbent paper material with a waterproof backing layer to provide maximum protection - the absorbent paper material helps prevent water “run-off” whilst the waterproof backing helps protect the patient’s clothes from splashes and spills during the ear irrigation procedure.” The ProScoop has already been nominated for an MEH Health and InnovationAward for Most Innovative New Product for Export in the ENT category. www.miragehealthgroup.com

Visit Mirage Health Group at Stand 8A 50

January 2011 | 35


Middle East Hospital

Obstructive Sleep Apnea OSA affects 4% of adults worldwide, but is often not diagnosed or treated. A new online survey conducted by Philips Healthcare Middle East indicates higher prevalence of the condition in the UAE

January 2011 | 36


Middle East Hospital Obstructive Sleep Apnea (OSA) is one of the most common sleep disorders worldwide. It is a condition that causes a person’s breathing to stop repeatedly during the night, causing disruption in their sleep as they struggle to breathe. As a result, they never get the deep, restorative sleep that is needed. OSA can not only negatively impact a person’s overall quality of life and productivity, but it can also potentially lead to serious health issues like increasing the risk of type 2 diabetes, high blood pressure, abnormal heart rhythm, strokes and other conditions.

Open airway

Individuals with moderate to severe OSA often have a number of symptoms including loud, disruptive snoring, gasping for air or choking during sleep, and excessive daytime sleepiness. OSA can easily be diagnosed by physicians upon assessing a patient’s complaints and symptoms. If sleep apnea is suspected, a patient will be referred for a diagnostic sleep study known as a polysomnogram (PSG), to confirm the type and severity of the sleep apnea, as well as the appropriate treatment. Survey indicates higher prevalence level of OSA in the UAE Philips conducted an online Sleep Apnea Awareness campaign titled ‘Do You Snore’, to help build public consciousness about Obstructive Sleep Apnea (OSA) in the UAE. Email invitations were sent out to fill out a short and straight forward survey to more than 20,000 recipients based in the country, targeting a sample group of the age 25 and above. Almost 6% of respondents showed positive results and are very likely to be suffering from OSA. The potential patients were advised to print their report and seek further medical advice and diagnostic tests for sleep apnea. Philips hosted the ‘2nd Gulf Sleep Apnea Meeting’ on the 16th of December, inviting sleep medicine

Obstructed airway clinicians from around the Gulf and Middle East to discuss the survey’s outcome and give deeper insights on topics related to sleep apnea such as Obstructive Sleep Apnea (OSA) and Cardiovascular Diseases, Sleep and Aging, as well as showcasing the latest solutions in OSA Therapy Systems.

most common form of sleep disorder breathing. Treating OSA can limit the risk of developing the life-threatening conditions mentioned earlier and improve quality of life”, he adds.

"Obstructive Sleep Apnea is the most common form of sleepdisordered breathing, affecting approximately 2% of women and 4% of men, globally. A large proportion of cases remain undiagnosed”, said Diederik Zeven, Senior Director and General Manager of Philips Healthcare Middle East. “Most people fail to seek medical diagnosis for this

January 2011 | 37


Middle East Hospital

“Philips Respironics is the international market leader, designer and manufacturer of Sleep Therapy Solutions. As a leader in the sleep market and the treatment of OSA, we design sleep therapy products that should help simplify healthcare providers’ work. Recently; we released an intelligent Sleep Therapy System to treat Obstructive Sleep Apnea (OSA). This new system represents the state of the art technology in the treatment of OSA”, said Mr Zeven, “It is a Continuous Positive Airway Pressure (CPAP) solution with intelligent technology that simplifies patient management by treating instead of monitoring patients and recognizing when therapy needs are changing, while offering sophisticated comfort enhancements.”

sleep, and excessive daytime sleepiness. However, only a fraction of such people have been diagnosed. OSA can easily be diagnosed by physicians upon assessing a patient’s complaints and symptoms. If sleep apnea is suspected, a patient will be referred for a diagnostic sleep study known as a polysomnogram (PSG), to confirm the type and severity of the sleep apnea, as well as the appropriate treatment.

Once OSA is diagnosed as the cause of a patient’s complaints and symptoms, it usually can be effectively treated with CPAP therapy, a non-invasive approach which is the standard treatment of choice for OSA. CPAP provides a gentle flow of air pressure through the nasal passage using a mask, preventing airway collapse to allow an OSA patient to breathe freely during sleep. The CPAP device is equipped with various features to increase patient comfort during therapy.

The vast majority of people fail to seek medical diagnosis for sleep disordered breathing. Individuals with moderate to severe OSA often have a number of symptoms including loud, disruptive snoring, gasping for air or choking during

January 2011 | 38


20

MEH

n tio va

michaeloko@me.com www.snorecentre.com www .snorecentre.com

lth and Inn Hea o 10

OfďŹ cial Nominee for 2010 Awards

SLEEP APNOEA VITALITY FOR LIFE

Healthcare Looking for Healthcar e Partners in the rregion egion

V Visit isit us at ST STAND TAND A 7 7E14


Middle East Hospital

Case Study - Bill's Sleep Apnea Story Like most people with obstructive sleep apnea (OSA), my diagnosis was the result of a loved one telling me about my snoring. While I was visiting my parents, I fell asleep watching TV. My Mom woke me and told me I was sleeping and snoring loudly. Of course I told her I wasn't. This went on for a year or so. When I visited my parents again, my Mom asked me if I had told my doctor I snored? I told her no. Finally I decided to tell my primary care doctor that my Mom told me I snored. He gave me a referral for a sleep study. My neck size is larger than 17 inches; I am overweight; my sister has Sleep Apnea; and I have Type 2 Diabetes. With all these classic symptoms, I fit the typical profile of someone diagnosed with Sleep Apnea. I still can't figure out why, with all the classic symptoms of OSA that my Primary Care Physician (PCP) didn't refer me for a sleep study sooner, besides not knowing I snored. He DID know I had all the classic symptoms (he just didn't know I snored). Once I informed him of that, he put it with everything he already knew and referred me to a sleep study. I strongly suggest that if someone tells you that you snore, that you let your Primary Care Physician know ASAP. Getting Diagnosed My sleep study was done on May 6, 2001. The sleep study technician told me that if the monitoring indicated that I had sleep apnea that he would wake me up and put a CPAP on me. (CPAP is an acronym for Continuous Positive Airway Pressure. The CPAP machine delivers pressurized air through tubing and a mask. The pressurized air acts as an air splint to hold open the airway while the patient sleeps.) Part way through the sleep study the technician did wake me up and put me on a CPAP. I slept GREAT...in fact it was the best sleep I had remembered in a long time.

The next morning the technician woke me at 6:00 AM and the study was over. I "unofficially" knew I had Sleep Apnea; however, before a patient can get a CPAP to bring home, the Sleep Doctor needs to "diagnose you", which in most cases is just reviewing what the technician did and writing it up. I Want My CPAP Since I now at least "unofficially" knew I had sleep apnea, I wanted a CPAP. For whatever reason, it took the sleep lab A MONTH to "officially" diagnose me. Since I have an HMO, the results went to my Primary Care Physician. Once my PCP had the results, he wrote a prescription for a CPAP, but due to HMO red tape, it needed HMO approval. The process of getting the HMO approval took a week. While I was waiting for the official results of the sleep study, I surfed the Internet and started researching Sleep Apnea. I found a site that sold CPAP equipment and saw various CPAP machines and masks. They had a link to the TalkAboutSleep website, which is THE BEST website that I've found. By the time I was officially diagnosed with Sleep Apnea, I had had a whole month to research the various CPAP machines and masks. My DME (Durable Medical Equipment provider -- home healthcare company) told me I needed a humidifier and he gave me one although I didn't yet have a prescription for it. I called my Primary Care Physician and had a prescription faxed over, which took two weeks. My Primary Care Physician had written the prescription for a GoldSeal mask, since that is what was used in my sleep study, but did sign the prescription where patient selection is permitted. My DME said that most people have good luck with the Breeze Nasal Pillows and the Breeze Nasal Pillows were also talked about in a Talk About Sleep online chat, so I took his advice and got it.

Thanks to an online discussion, I have a backup DC power supply for my CPAP, so that when the power goes out, I can plug my CPAP into the DC power supply. I ended up getting Instant Power, sold at Sears for around $70 and got the DC power cable for my CPAP from my Durable Medical Equipment store. Note that not all CPAP machines have DC Power, in which case you have to get an inverter. I want to sleep with my CPAP even if I don't have electricity. I was without electricity 48 hours this past winter when an ice storm took the power out. The Instant Power has a secondary purpose, which is to be in my truck, in case my battery doesn't turn over. It has jumper cables on it, so I can jump-start my truck. Feeling Great! It's been a little over a month since I started using a CPAP and I have been sleeping MUCH better and will not sleep without my CPAP machine. It has enabled me to watch TV shows and not fall asleep. I also feel like I have more energy and walked to the store (a five to ten minute walk one way) whereas before I would have driven my truck. Since using the CPAP I feel like I have MUCH more energy! I have started walking on Saturday's. The trick is to leave my apartment in time, so that I will be home prior to 9:30 AM (at least in the summer) when the temperature often is higher than 100 degrees. Prior to using the CPAP, I use to wake up around 3 AM every morning to go to the bathroom, then I would get something to eat. This led to weight gain. Since being on the CPAP I no longer wake up at 3 AM. The last time I went to the doctor, his nurse told me I lost two pounds. I hope the weight loss continues. My blood pressure is lower, and my doctor and I are watching it. Hopefully at some time I in the future I'll be able to get off of the hypertension medication all together. Case study provided by Philips Healthcare

January 2011 | 40


Middle East Hospital

Interview with Dr Michael Oko - Consultant ENT surgeon and founder of The Snoring Disorders Centre are the group most commonly present in the clinics, with a history of loud snoring and fatigue. Mr Oko told MEH, “The treatment of this condition can have a profound effect on transforming the quality of patients lives, and can be treated at a very reasonable cost. Also, due to the strong link between OSA and road traffic accidents (RTA) there are huge societal benefits of both raising awareness and treatment of the condition.

Dr Michael Oko

The Snoring Disorders Centre at The Bostonian in Lincolnshire, UK, was founded in 2006 by Mr Michael Oko, Consultant ENT Surgeon, to develop exceptional services to patients for the diagnosis and treatment of obstructive sleep apnoea (OSA). OSA has been prevalent for many years and is associated with obese patients in two thirds of cases, but this condition has always been misunderstood the public and politicians. With the obesity epidemic which is spreading across the world, and in particular in developed and wealthy countries, the impact on society of this chronic condition is becoming more apparent. Although about 20% of the population snore, OSA is thought to affect between 2 and 4% of the population and is at least twice as common in males as females. In practice overweight males in sedentary occupations (lorry driver for example) in their 30s and 40s

“It is suspected that about 20% of car accidents are thought to be sleep related and research has show that it can impair driving more than drink. Indeed patients with OSA have a 7-12 fold chance of a road traffic accident (RTA) compared to those who do not and treating the condition can reduce accident rates by 83%. It has been reported that up to 1:6 Heavy Goods Vehicle (HGV) drivers are thought to have OSA and some Unions are calling for mandatory testing for all drivers. Falling asleep at the wheel results in far more serve injuries and likelihood of death as there is no attempt at breaking and evasive manoeuvres”.

At the time when Mr Oko founded the Snoring Disorders Centre in 2006 there was no OSA service in Lincolnshire even though local clinicians had been trying to develop these for over a decade in a population group that is the most obese in Europe and over 79 fatal accidents per year (each costing £1.49 million). The Medical Director of United Lincolnshire Hospitals Trust asked Mr Oko to solve this problem with a private sector model which would provide a solution to this problem.

Visit Dr Michael Oko at stand 7E 14

January 2011 | 42


Middle East Hospital There were significant challenges to this as the Trust did not have a list of identified cases, no clinic space and no equipment for diagnostics or treatment and no agreed commissioning agreements form the local healthcare organisations. They was also a substantial hurdle to overcome in terms of educational awareness about the condition amongst the local population and General Practitioners. Working with the Local Trust in a 50:50 partnership arrangement all these obstacles were rapidly overcome, with Mr Oko taking responsibility for the purchase and provision of all diagnostic and treatment equipment and giving half of the tariff income back to the NHS. Mr Oko will be attending Arab health in Dubai and is seeking to replicate his success in Lincolnshire across the Middle East with local partners over the next 5 years, and he will also be attending Saudi Medicare in April 2011. Asked about his interest in the Middle East region, Mr Oko explained, “Levels of obesity, hypertension and heart disease are rocketing in the wealthy Middle East, mainly due to the life-style out there. People are working long hours, eating rich calorie-laden food, driving everywhere and not exercising enough. Being overweight can result in snoring which is a major cause of obstructive sleep apnoea, when a person temporarily stops breathing many times during the night. This deprives people of deep REM sleep and results in drowsiness and fatigue the next day. It’s when we’re tired that we make mistakes – especially whilst driving. So it’s no surprise that road accident rates out in Dubai and the UAE are dreadful. “In fact road traffic accidents are the second major cause of deaths in the UAE. There are 3500 fatalities per year from RTAs in Saudi Arabia

www.snorecentre.com michaeloko@me.com

SLEEPING DISORDERS THE SNORING DISORDERS CENTRE IS A NEW AND INNOVATIVE SERVICE LED BY CONSULTANT SURGEON MR MICHAEL OKO. The centre provides an accurate and prompt diagnosis and treatment of various sleep problems including sleep apnoea and snoring. Problem snoring and sleep apnoea are a more widespread problem than most people think. AWARD WINNING SERVICES In 2008 the Snoring Disorders Centre won the NHS East Midlands Healthcare Award for service transformation. Today, patients travel the length and breadth of the country for Mr Oko's unique service. Our aim is to deliver high quality clinical care in a friendly environment. We are looking for partners throughout the region

www.snorecentre.com

Signs of Sleep Apnoea • Loud snoring • Breath holding at night (apnoea) • Daytime fatigue • Short term memory loss • Multiple trips to urinate through the night • Early morning headaches • Loss of interest in sex

michaeloko@me.com

OUR SERVICES

CPAP FOR SLEEP APNOEA

LIFESTYLE CHANGES

SURGERY FOR SNORING

MANDIBULAR DEVICES

While you sleep, a CPAP machine delivers oxygen and air at a slightly higher pressure than normal air.

Changes to your life alone can enhance your sleep and help prevent sleep apnoea and snoring.

Surgery that changes the shape or size of the soft tissues within your mouth or ear, nose and throat surgery.

Devices to stop your jaw and tongue blocking your airway and causing snoring to wear at night.

alone, and OSA is a possible explanation for this in some cases. I believe that the success I have had in Lincolnshire can be replicated by raising awareness of the condition, and forming longterm partnerships with local hospitals, doctors, and government

departments”. Mr Oko emphasises the importance of working with all relevant agencies to tackle this issue, not just in the healthcare field, but also in transport and road safety. www.snorecentre.com Michael.Oko@ULH.nhs.uk

Short biography Michael Oko has been a Consultant ENT Surgeon for 5 years and head of Dept of Sleep Services for 4.5yrs, ENT for 3yrs and general surgery for 1 yr. He qualified in 1986 and trained in London (St Mary’s & Royal National Throat, Nose & Ear) & Glasgow and was a Lecturer at the University of Glasgow in ENT Surgery and was one of the 12 finalists in 2005 for the Surgeon in Training medal, organised by the largest College of Surgeons in the world, The Royal College of Surgeons Edinburgh for instrument design and innovation. By 2008 Mr Oko had won the East midlands NHS Healthcare awards for service transformation and road fatalities had dropped to 52 saving over £40 million per year in Lincolnshire at a cost of approximately 1million per year. In 2010 he was asked to present his project and findings by the Health Services Journal (HSJ) to all commissioners of ENT services and his peer group in the UK and had treated over 1500 patients of which 1200 are on CPAP and the road fatalities continue to be stabilised at 52 per annum. In November 2010 he was nominated for the prestigious “Excellence in Respiratory health Award” by Middle East Hospital magazine.

January 2011 | 43


Middle East Hospital

World Health Care Congress Middle East review The Inaugural World Health Care Congress Middle East is the most prestigious health care event convening global thought leaders and key decision makers from all sectors of health care to share global best practices on health care innovation and improvement. The 2010 Congress took place in Abu Dhabi, UAE. The Congress featured some of the leading healthcare experts in the region and from all over the world. Including keynote speeches from an impressive Saudi presence represented by Walid Fitahi CEO of IMC Hospital Jeddah and Abdullah Amro CEP King Fahad Medical City, Sultan Al Sudeiry Head of Research Centre King Faisal Hospital. Also in attendance was Michael Reid Director General of Queensland Health in Australia. The event was compered by Riz Khan, presenter on Al Jazeerah. “Abu Dhabi is committed to continuous improvement, innovation and excellence in health care for all of its residents, the Middle East in general, and to inspire health innovation and improvement world wide. We envisage the event attracting a high regional and international turnout of health care executives, providers, and government leaders to explore fresh ideas and unique insights,” said CEO of Health Authority - Abu Dhabi (HAAD) Zaid Al-Siksek. “The topics to be addressed will be actionable and strategic, designed to address local and global challenges in quality, cost effectiveness, outcomes and new models for finance and improvements in delivery.” “There is an increasing amount of innovation in health care throughout the world, yet often dramatically better health delivery practices and outcomes are not even widely recognized within their own countries,” said WHCC Chairman

Vishal Bali–CEO Fortis Hospital Group; Hamad Al Yami King Faisal Hospital; Ali Al Sanousi, King Faisal Hospital Mike Tanousis, Aspetar Qatar, Riz Khan

Vidar Jorgenson. “Abu Dhabi is providing a great service by sponsoring a World Health Care Congress that will focus on innovation, identifying and promoting these important health care innovations with recognition throughout the world, inspiring even more health innovation and sharing in the future.” World Health Care Congress highlights health issues Several important announcements were made at this year’s World Health Care Congress Middle East

held at the Beach Rotana Hotel 5th – 7th December. The congress saw a gathering of 500 global health care leaders share best practices for the future of health care in the UAE, the GCC countries and abroad. On Sunday, the Health Authority Abu Dhabi (HAAD), the regulator of the healthcare sector in the Emirate of Abu Dhabi, announced a plan to improve health care delivery in the Emirate by sharing information about the quality of care patients receive and the clinicians who provide healthcare. The initiative

January 2011 | 44


Middle East Hospital

World Health Care Congress Middle East review Sultan Al Sedairy – Head of Research King Faisal Hospital,Steven Burrill CEO Burrill & Co

Hussein Ekbal Abu DHABI Health Authority; Dr Abdullah AL Amro, CEO King Fahad Medical City

marks the first time Abu Dhabi will publish detailed clinical indicators based on routine data collection. Dr Philip Vetter, head of strategy at HAAD, said, “These are the first of a series of indicators developed by the Clinical Quality Panel. Using international indicators as a basis they give good insight into the quality of care being delivered.” On Monday, HAAD also announced the official launch of an Innovators’ Forum, a collection of initiatives from a broad range of academic, non-governmental organisation and private sector entities, focused on the development of new products and services for preventing and treating the growing burden of chronic diseases in the Emirate.

as the region brings together a rare combination of circumstances for innovation: strong leadership, unique health data, and solid resources, and a unique health data system encompassing both UAE Nationals and expatriates.” The urgency of these announcements was highlighted by the presentation of a report

on Tuesday, Diabetes in the United Arab Emirates: Crisis or Opportunity?, which estimates that 32 percent of the country’s adult population, including both UAE nationals and expatriates, may have diabetes or prediabetes by 2020 at a cost of AED 31.27 billion over the next decade if current trends continue.

Zaid Al Siksek CEO Health Authority Abu Dhabi

The Innovators’ Forum will include a diverse community of leading global health care entities interested in working with HAAD to achieve a shared goal of improving the public health. HAAD CEO Zaid al Siksek said, “Abu Dhabi offers a prime opportunity to gather stakeholders and impact health,

January 2011 | 45


Middle East Hospital Access to healthcare a m ajor challeng e Universal access to healthcare and sustainability are major challenges faced by many countries across the globe, experts said on the first day of The World Health Care Congress (WHCC) Middle East.

Dr Prem Jaygasi and Mike Tanousis

“I think the challenge of universal access is enormous and have a long way to go,” said Michael Reid, Director-General of Queensland Health in Australia, noting that the factors affecting access included the challenge of affordability, availability and healthcare delivery. Speaking at the inaugural conference in Abu Dhabi, Reid also stressed that sustainability remains a core issue of health systems worldwide. In Abu Dhabi, 98 per cent of the 2.2 million population have health insurance coverage allowing residents instant access to healthcare, and this was made possible by the reformation of the emirate’s health system three years ago. “We focus on three main areas in Abu Dhabi, to provide the best and the highest standard of care for all patients, to provide access wherever it may be throughout our health system and provide affordable healthcare to our stakeholders and customers,” said Zaid Al Siksek, CEO of the Health Authority-Abu Dhabi (HAAD). But to sustain the government’s vision, certain elements of the health system need to be further reformed. These include creating a transparent database, establishing specialist healthcare facilities to cater to various needs of the patients, providing incentives to the foreign workforce, developing a consumer-driven healthcare to drive innovation and the transformation of chronic disease management. “Hospitals cannot do anything and everything, hospitals need to be specialised as 2.2 million people cannot afford to do everything in

Ahmed Okasha, Milton Ioannides, Riz Khan

every single hospital. One of the things we push for is the need to be specialised, and be able to focus healthcare onto groups where we can become much better at what we’re doing and provide the threshold that are needed to provide sustainable quality,” said Siksek. Noting the important role of physicians in the health system, Siksek proposed the need to give them incentives in addition to their salaries, which ultimately will give them the feeling of ownership. “We depend on the foreign workforce in Abu Dhabi. About 85-90 per cent of our workforce is not from within the UAE. We need to give them incentives that are more than pay. Surely we cannot convince them to stay and help transform the healthcare system with just pay. They need to feel part of the health system and this is something that we’re looking to

transform and integrate in the system,” Siksek disclosed. On transforming chronic disease management, Siksek said: “Chronic disease was something that we have to integrate into the reform process as unfortunately in Abu Dhabi, we have no choice. Our population is relatively young at an average age of 28, and chronic diseases are staggering. The number of diabetics among the UAE national population is about 22 per cent.“We are looking at a huge challenge in the next 20 years and it doesn’t look like it’s going to get better,” he added. The next show will be held 11-13 December 2011Abu Dhabi Middle East Hospital are the official media partners to the show and you can find further details on www.worldcongress.com/events/HR11004/

January 2011 | 46


medibord.com

World First Technology Medibord™ The Medibord™ has been designed to enable the development of innovative solutions for radiotherapy and MRI compatible medical devices and clinical use.          

     • Lightweight – less than 4.5kg/m² • Rigid – impressive strength to weight ratio • Robust – high impact resistance offers superb durability • Ecological – 100% recyclable • MRI Compatible – uniquely magneto-radio translucent • Modular – ability to form and offer 2D for shaping cost effective ancillaries

Successful clinical trials carried out by Nottingham University Hospitals have proved the MedibordÂ&#x2122; to be a revolutionary material for the use in radiotherapy and MRI scans       #*  +     < eliminating heat and the resultant image artefacts. *  +         Â&#x2022; Oncology couch tops Â&#x2022; Patient positioning boards and devices Â&#x2022; Patient transfer systems Â&#x2022; Emergency and temporary partitioning Â&#x2022; Clinical waste applications

Most Innovative Product for Export

For more information and to arrange for a clinical trial please contact us.

*  +#=  <#>

< [#\  #\]^^]_ Â&#x2022;`{^^}~Â&#x20AC;Â Â&#x2022; info@medibord.com


Middle East Hospital

Special feature: Diabetes in the Gulf and MENA region According to an International Diabetes Federation report six countries in the Middle East and North African Region are among the world’s 10 highest for diabetes prevalence and a similar situation applies for the IGT prevalence. These countries are Bahrain, Egypt, Kuwait, Oman, Saudi Arabia and United Arab Emirates. The ageing of populations, together with socio-economic and lifestyle changes, has resulted in the dramatic increase in diabetes prevalence. Over the past three decades, major social and economic changes have occurred in the majority of these nations. These include progressive urbanization, decreasing infant mortality and increasing life expectancy. Rapid economic development, especially among the more wealthy oil-producing countries, has been associated with tremendous modification in lifestyle towards the westernized pattern reflected by changes in nutrition, less physical activity, tendency to increased obesity and more smoking. The explosion of diabetes in the MENA Region is mainly due to type 2 diabetes. As with many other countries with high diabetes prevalence, the onset of type 2 diabetes tends to occur at a relatively young age. An estimated 26.6 million people, or 7.7% of the adult population, will have diabetes in 2010, with the number expected to nearly double in the next 20 years. Similarly, the number of people with IGT is also expected to rise markedly by 2030, raising the likelihood of further increases in the prevalence of diabetes as the century proceeds.

Reliable data for type 1 diabetes in children were also available in a number of countries in this region. By far the largest contribution to the total number of children with type 1 diabetes comes from Egypt whose estimates accounts for almost a quarter of the region’s total of 54,000 cases. The range of reported incidence varies from 22.3 per 100,000 aged 0-14 years per year in Kuwait to less than 1 per 100,000 aged 0-14 years in Pakistan. Diabetes is the expected cause of some 290,000 deaths in this region, which will account for 11.5% of all deaths in the 20-79 age group in 2010. More women than men are expected to die from diabetesrelated causes. In the 50-59 age group, mortality attributable to diabetes in women accounts for more than 20% of all deaths. In spite of the high estimates of diabetes prevalence in the MENA Region, the total healthcare expenditure for diabetes is expected to be only USD5.6 billion for the whole region. This is projected to account for only 1.5% of global spending. People with diabetes in the 50-59 age group are expected to incur the highest costs. A high percentage (80%) of countries that responded to the IDF member association survey indicated the existence of a national diabetes programme. In the majority of these countries, the NDP had been implemented. Primary prevention as well as screening and early diagnosis are important areas of focus in many of the NDPs in this region of extremely high diabetes prevalence. At the same time, NDPs monitored community awareness, and the prevalence and incidence of diabetes in their efforts to deal with the diabetes burden. Treating the disease The Gulf Diabetes Specialist Center (GDSC) Medical Director is Dr. Wiam Hussein , a consultant

Dr Maha Taysir Barakat

endocrinologist from Cleveland, USA , who is one of the best known names in the treatment of diabetes and endocrine disorders in the Middle East. Asked about the causes of a high prevalene of diabetes in the region Dr Hussein told MEH, “Diabetes type 2, the most common type, is genetically determined but what has changed is the environment in the last 2 decades leading to more sedentary lifestyle and poor eating habits that led to an epidemic of Obesity. Obesity is the strongest risk factor for diabetes. The prevalence in the Gulf countries is considered the highest in the world and it is thought it will double in the next two decades. We can increase diabetes awareness and diagnose it earlier to prevent the devastating complications of the disease nut we can also prevent the disease by changing the poor eating habits, improve lifestyle towards healthier ones and prevent obesity.” GDSC in Bahrain is the region's first medical center devoted entirely to the treatment of diabetes and its related complications. In Bahrain prevalence rate of diabetes mellitus is 14.4% of the population, double the MENA average of 7.7%.

January 2011 | 48


2010 HEALTH and INNOVATION AWARDS

h and Innov t l a at He

ward nA io

MEH 2 01 0

Nominations now open

outstanding contribution to healthcare in the Middle East

The Arab regionâ&#x20AC;&#x2122;s leading healthcare monthly, Middle East Hospital magazine (MEH), are proud to announce the opening of nominations for our 2010 Healthcare and Innovation Awards.

Winners will be presented with their awards at Saudi Medicare 2011 by the Saudi Health Minister. The MEH Healthcare and Innovation awards are presented annually to companies, institutions and individuals who have made an outstanding contribution to healthcare in the Middle East region.

Categories: 1. Awards for most innovative products for export 2. Awards for outstanding contribution to healthcare in the Middle East 3. National and regional awards for companies that have most successfully marketed and supplied their products to hospitals in the Middle East 4. MEH excellence in healthcare awards Middle East Hospital (MEH) magazine is the regionâ&#x20AC;&#x2122;s leading trade publication for the medical sector of the GCC states and the rest of the Arab world.

To enter your company or hospital contact: editorial@middleeasthospital.com or visit

www.middleeasthospital.com


Middle East Hospital Dr Maha Taysir Barakat was there when the doors opened at the Imperial College London Diabetes Centre in Abu Dhabi nearly four years ago. “At first, we would see about five patients a day, then it was ten a day, and it built to 200 patients a day,” recalls Dr Barakat, the consultant endocrinologist and director of medical and research at the hospital. “Now it’s exceeding 300 a day.” Since that day in August 2006 more than 20,000 patients have visited the hospital, particularly for diabetes, which is prevalent in the UAE. Managing diabetes is a large focus for healthcare providers and spending by governments in the region. There are two main types of the disease: Type 1 is most commonly evident from early childhood and sufferers are dependent on insulin; while Type 2, also known as adult-onset diabetes, has been linked to obesity and other lifestyle factors. In Abu Dhabi, nearly a third of Emiratis are overweight and one in four shows evidence of having the disease, government health statistics show. Nationally, the figure is about 20 per cent. About 25 per cent of Emirati men and almost 40 per cent of women in the country are classified as obese, which puts a further strain on medical facilities. Treating those patients could cost the nation more than Dh440 million (US$119.7m) a year, according to research from UAE University. Mubadala Healthcare, a division of Mubadala Development, which is a strategic investment company owned by the Abu Dhabi Government, has partnerships with international medical organisations. The link-up involves Mubadala providing the capital while the medical groups offer technology, expertise and staff. The investment company opened the Imperial College London centre and it is building the Cleveland Clinic Abu Dhabi, which is due to open in

2012. Imperial College London Diabetes Centre (ICLDC) was one of the first facilities to be established as part of Mubadala Healthcare’s vision to create a world-class healthcare network in Abu Dhabi. The Centre is a prime example of how this vision is being realised - addressing one of the most pressing healthcare issues in the region by harnessing the worldrenowned medical expertise of Imperial College London and creating a centre of excellence for Abu Dhabi. Costs of diabetes epidemic is rocketing Through economic boom and bust health care has remained on an upward trajectory, posting year after year of growth as healthcare providers throughout the world cope with the demands of an ageing population. In the GCC, demand for care largely comes from populations that suffer higher rates of obesity-related diseases such as diabetes and cardiovascular illnesses. Various estimates have the value of the GCC’s healthcare sector at between US$ 15 billion and US$ 18bn a year, a total that should increase five-fold by 2025. The growth in demand is fuelled by both the governments in the Gulf and the citizens they serve, says Ameera Youssef, the business director at Acorn Research Group in Dubai. “Governments are getting smarter,” Ms Youssef says. “Patients are

more aware of their rights; they don’t want to accept the standards of health care of the past.” To meet those demands, the UAE Ministry of Finance has said 6.4 per cent of its total budget of Dh43.6bn this year will go to health care. Abu Dhabi is investing heavily in its healthcare infrastructure as its health authority plans to add 2,000 hospital beds to the existing 3,642 in the next 10 years. But even with that dedicated funding, health budgets could still be stretched to the limit to match demand from a population that is increasing each year. Acorn Research predicts that projected spending in the GCC by 2025 will top US$ 57.3bn. But analysts warn even that might not be enough. Alpen Capital, a Dubai investment bank, cautions that the region needs to add more than 27,000 beds to meet international standards. But Dr Baraket says the region’s growing healthcare needs are not going to be met merely through investment in infrastructure and having patients visit doctors in hospitals. “There is no point in a patient seeing a doctor who just gives tablets,” she says. “They need to understand what they should and shouldn’t do, what they should and shouldn’t eat, especially since they only see the doctor, say, three or four times a year. This is 365 days a year.”

January 2011 | 50


MEH

20

lth and Inn Hea o 10

n tio va

Come and visit us at

Arab Health Stand Number

7H 58

OfďŹ cial Nominee for 2010 Awards


Middle East Hospital Magazine January 2011